{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:51:08Z","timestamp":1792281068217,"version":"4.4.0"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NHLBI","award":["R01HL118183"],"award-info":[{"award-number":["R01HL118183"]}]},{"name":"NIH\/NHLBI","award":["F31 HL112665-01A1"],"award-info":[{"award-number":["F31 HL112665-01A1"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.clim.2016.11.010","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T12:45:14Z","timestamp":1480077914000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"special_numbering":"C","title":["Natural killer cells in inflammatory heart disease"],"prefix":"10.1016","volume":"175","author":[{"given":"SuFey","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel R","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"\u010cih\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clim.2016.11.010_bb0005","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1073\/pnas.0510997103","article-title":"Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction","volume":"103","author":"Ayach","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1253\/jcj.57.37","article-title":"Immunological aspects in patients with acute myocardial infarction","volume":"57","author":"Kuroki","year":"1993","journal-title":"Jpn. Circ. J."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0015","first-page":"209","article-title":"Depressed natural killer cell activity in acute myocardial infarction","volume":"70","author":"Klarlund","year":"1987","journal-title":"Clin. Exp. Immunol."},{"issue":"8308","key":"10.1016\/j.clim.2016.11.010_bb0020","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(82)92786-6","article-title":"Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy","volume":"2","author":"Anderson","year":"1982","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cyto.2013.12.003","article-title":"Peripheral depletion of NK cells and imbalance of the Treg\/Th17 axis in idiopathic pulmonary fibrosis patients","volume":"66","author":"Galati","year":"2014","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.clim.2016.11.010_bb0030","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/TP.0000000000000405","article-title":"Natural killer cells play a critical role in cardiac allograft vasculopathy in an interleukin-6--dependent manner","volume":"98","author":"Zhang","year":"2014","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0035","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.114.001583","article-title":"Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial","volume":"7","author":"Shah","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"17","key":"10.1016\/j.clim.2016.11.010_bb0040","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The incidence of pediatric cardiomyopathy in two regions of the United States","volume":"348","author":"Lipshultz","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0045","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ajpath.2014.11.023","article-title":"Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration","volume":"185","author":"Ong","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2016.11.010_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fphys.2014.00295","article-title":"Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction","volume":"5","author":"Knorr","year":"2014","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells--a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2016.11.010_bb0060","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","article-title":"Innate lymphoid cells: emerging insights in development, lineage relationships, and function","volume":"30","author":"Spits","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri3629","article-title":"Innate lymphoid cells: on the origin of ILCs","volume":"14","author":"Bordon","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2016.11.010_bb0070","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nri3480","article-title":"Mucosal immunology: ILCs broker peace deals in the gut","volume":"13","author":"Bordon","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.coi.2013.02.002","article-title":"Developmental programming of natural killer and innate lymphoid cells","volume":"25","author":"Vosshenrich","year":"2013","journal-title":"Curr. Opin. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2016.11.010_bb0080","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/ni.3248","article-title":"TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow","volume":"16","author":"Yang","year":"2015","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","article-title":"Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages","volume":"157","author":"Klose","year":"2014","journal-title":"Cell"},{"issue":"7496","key":"10.1016\/j.clim.2016.11.010_bb0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature13047","article-title":"A committed precursor to innate lymphoid cells","volume":"508","author":"Constantinides","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1471-4906(00)01802-0","article-title":"Divergent and convergent evolution of NK-cell receptors","volume":"22","author":"Barten","year":"2001","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri3370","article-title":"Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution","volume":"13","author":"Parham","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2016.11.010_bb0105","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.4049\/jimmunol.1001494","article-title":"Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells","volume":"185","author":"Older Aguilar","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.0902332","article-title":"Variable NK cell receptors exemplified by human KIR3DL1\/S1","volume":"187","author":"Parham","year":"2011","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2016.11.010_bb0115","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-08-3712","article-title":"Expansion of highly cytotoxic human natural killer cells for cancer cell therapy","volume":"69","author":"Fujisaki","year":"2009","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"issue":"1 Pt 2","key":"10.1016\/j.clim.2016.11.010_bb0125","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1006\/clim.1999.4816","article-title":"The origin and functions of natural killer cells","volume":"95","author":"Lanier","year":"2000","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clim.2015.03.008","article-title":"Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3","volume":"158","author":"Golden-Mason","year":"2015","journal-title":"Clin. Immunol."},{"issue":"6013","key":"10.1016\/j.clim.2016.11.010_bb0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.clim.2016.11.010_bb0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-032712-100001","article-title":"Control of human viral infections by natural killer cells","volume":"31","author":"Jost","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2016.11.010_bb0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ni.2032","article-title":"Natural killer cell memory","volume":"12","author":"Paust","year":"2011","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nri.2015.9","article-title":"Natural killer cell memory in infection, inflammation and cancer","volume":"16","author":"Cerwenka","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2016.11.010_bb0155","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ni.1953","article-title":"Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses","volume":"11","author":"Paust","year":"2010","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0160","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ni1332","article-title":"T cell- and B cell-independent adaptive immunity mediated by natural killer cells","volume":"7","author":"O'Leary","year":"2006","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2016.11.010_bb0165","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ni.3227","article-title":"Antigen-specific NK cell memory in rhesus macaques","volume":"16","author":"Reeves","year":"2015","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2016.11.010_bb0170","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ni796","article-title":"In vivo developmental stages in murine natural killer cell maturation","volume":"3","author":"Kim","year":"2002","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2016.11.010_bb0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nri3044","article-title":"NK cell development, homeostasis and function: parallels with CD8(+) T cells","volume":"11","author":"Sun","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2016.11.010_bb0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.immunol.24.021605.090700","article-title":"Natural killer cell developmental pathways: a question of balance","volume":"24","author":"Di Santo","year":"2006","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0185","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice","volume":"191","author":"Kennedy","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2016.11.010_bb0190","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.24.021605.090727","article-title":"Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis","volume":"24","author":"Ma","year":"2006","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0195","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1084\/jem.20131560","article-title":"T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow","volume":"211","author":"Daussy","year":"2014","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/cmi.2012.8","article-title":"Single line or parallel lines: NK cell differentiation driven by T-bet and Eomes","volume":"9","author":"Jiang","year":"2012","journal-title":"Cell. Mol. Immunol."},{"issue":"20","key":"10.1016\/j.clim.2016.11.010_bb0205","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1182\/blood-2011-04-348912","article-title":"Identification of the earliest natural killer cell-committed progenitor in murine bone marrow","volume":"118","author":"Fathman","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clim.2016.11.010_bb0210","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.4049\/jimmunol.169.8.4153","article-title":"Enforced expression of Bcl-2 restores the number of NK cells, but does not rescue the impaired development of NKT cells or intraepithelial lymphocytes, in IL-2\/IL-15 receptor beta-chain-deficient mice","volume":"169","author":"Minagawa","year":"2002","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2016.11.010_bb0215","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood-2002-10-3293","article-title":"Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD\/SCID mice","volume":"102","author":"Beider","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clim.2016.11.010_bb0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0065-2776(08)01002-X","article-title":"Natural killer cell tolerance licensing and other mechanisms","volume":"101","author":"Jonsson","year":"2009","journal-title":"Adv. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2016.11.010_bb0225","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1182\/blood-2013-02-483503","article-title":"Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses","volume":"122","author":"Sungur","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.clim.2016.11.010_bb0230","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nri3065","article-title":"Organ-specific features of natural killer cells","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12026-013-8477-9","article-title":"Organ-specific phenotypic and functional features of NK cells in humans","volume":"58","author":"Sharma","year":"2014","journal-title":"Immunol. Res."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0240","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.4049\/jimmunol.0901362","article-title":"Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state","volume":"184","author":"Lassen","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2016.11.010_bb0245","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clim.2016.11.010_bb0250","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.0813192106","article-title":"Cytokine-induced memory-like natural killer cells","volume":"106","author":"Cooper","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.clim.2016.11.010_bb0255","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.4049\/jimmunol.180.12.7818","article-title":"The innate NK cells, allograft rejection, and a key role for IL-15","volume":"180","author":"Kroemer","year":"2008","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2016.11.010_bb0260","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MOT.0b013e3283061115","article-title":"The innate natural killer cells in transplant rejection and tolerance induction","volume":"13","author":"Kroemer","year":"2008","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0265","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.semcancer.2006.07.005","article-title":"Tumor and viral recognition by natural killer cells receptors","volume":"16","author":"Arnon","year":"2006","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0270","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0275","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00197084","article-title":"Role of natural killer cells in experimental murine myocarditis","volume":"11","author":"Gauntt","year":"1989","journal-title":"Springer Semin. Immunopathol."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0280","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1536\/ihj.31.741","article-title":"Idiopathic myocarditis associated with T-cell subset changes and depressed natural killer activity","volume":"31","author":"Kanda","year":"1990","journal-title":"Jpn. Heart J."},{"issue":"6","key":"10.1016\/j.clim.2016.11.010_bb0285","first-page":"337","article-title":"Natural killer cell activity and induction of alpha and gamma interferon in patients with Coxsackie B viral myocarditis","volume":"16","author":"Yang","year":"1988","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"10","key":"10.1016\/j.clim.2016.11.010_bb0290","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJMra1203528","article-title":"Behavioral and dietary risk factors for noncommunicable diseases","volume":"369","author":"Ezzati","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0295","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra1112570","article-title":"A tale of coronary artery disease and myocardial infarction","volume":"366","author":"Nabel","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0021-9150(00)00608-0","article-title":"Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice","volume":"156","author":"Hsich","year":"2001","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrmicro796","article-title":"Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?","volume":"2","author":"Campbell","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"issue":"9","key":"10.1016\/j.clim.2016.11.010_bb0310","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.4049\/jimmunol.1001879","article-title":"IL-17A is proatherogenic in high-fat diet-induced and chlamydia pneumoniae infection-accelerated atherosclerosis in mice","volume":"185","author":"Chen","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2012.02.009","article-title":"Increased expression of T cell immunoglobulin- and mucin domain-containing molecule-3 on natural killer cells in atherogenesis","volume":"222","author":"Hou","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clim.2016.11.010_bb0320","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-4933-4-3","article-title":"NK cell compartment in patients with coronary heart disease","volume":"4","author":"Hak","year":"2007","journal-title":"Immun. Ageing"},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0325","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.atherosclerosis.2005.03.011","article-title":"Loss of natural killer cell activity in patients with coronary artery disease","volume":"183","author":"Jonasson","year":"2005","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0330","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/cei.12210","article-title":"Natural killer (NK) cell deficit in coronary artery disease: no aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation","volume":"175","author":"Backteman","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2016.11.010_bb0335","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2016.11.010_bb0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fimmu.2012.00071","article-title":"Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis","volume":"3","author":"Ueha","year":"2012","journal-title":"Front. Immunol."},{"issue":"9351","key":"10.1016\/j.clim.2016.11.010_bb0345","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.clim.2016.11.010_bb0350","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1997.03550230069040","article-title":"Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review","volume":"278","author":"Weaver","year":"1997","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0355","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.91.2.476","article-title":"Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials","volume":"91","author":"Michels","year":"1995","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.clim.2016.11.010_bb0360","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/ATVBAHA.113.301437","article-title":"Angiotensin II-induced vascular dysfunction depends on interferon-gamma-driven immune cell recruitment and mutual activation of monocytes and NK-cells","volume":"33","author":"Kossmann","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0365","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cyto.2011.09.023","article-title":"Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction","volume":"56","author":"Bouchentouf","year":"2011","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.clim.2016.11.010_bb0370","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.4049\/jimmunol.1001888","article-title":"Induction of cardiac angiogenesis requires killer cell lectin-like receptor 1 and alpha4beta7 integrin expression by NK cells","volume":"185","author":"Bouchentouf","year":"2010","journal-title":"J. Immunol."},{"issue":"6983","key":"10.1016\/j.clim.2016.11.010_bb0375","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature02446","article-title":"Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts","volume":"428","author":"Murry","year":"2004","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0380","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nm1040","article-title":"Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation","volume":"10","author":"Nygren","year":"2004","journal-title":"Nat. Med."},{"issue":"6983","key":"10.1016\/j.clim.2016.11.010_bb0385","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nature02460","article-title":"Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium","volume":"428","author":"Balsam","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0390","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2249.2002.01741.x","article-title":"Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy","volume":"127","author":"Ankersmit","year":"2002","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2016.11.010_bb0395","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.4049\/jimmunol.179.10.6416","article-title":"The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection","volume":"179","author":"Kim","year":"2007","journal-title":"J. Immunol."},{"issue":"2\u20134","key":"10.1016\/j.clim.2016.11.010_bb0400","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0966-3274(02)00033-3","article-title":"NK cells and transplantation","volume":"9","author":"Hsieh","year":"2002","journal-title":"Transpl. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0405","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood-2006-10-048173","article-title":"The unexpected effect of cyclosporin A on CD56+CD16\u2212 and CD56+CD16+ natural killer cell subpopulations","volume":"110","author":"Wang","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clim.2016.11.010_bb0410","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1084\/jem.20060603","article-title":"NK cells promote transplant tolerance by killing donor antigen-presenting cells","volume":"203","author":"Yu","year":"2006","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.clim.2016.11.010_bb0415","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nm1296","article-title":"NK cells promote islet allograft tolerance via a perforin-dependent mechanism","volume":"11","author":"Beilke","year":"2005","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0420","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1600-6143.2005.01226.x","article-title":"Role of natural killer cell subsets in cardiac allograft rejection","volume":"6","author":"McNerney","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0425","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","article-title":"A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody","volume":"12","author":"Hirohashi","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.clim.2016.11.010_bb0430","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/01.CIR.96.6.2069","article-title":"Cardiac allograft vasculopathy: a review","volume":"96","author":"Weis","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0435","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20121964","article-title":"Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages","volume":"210","author":"Molofsky","year":"2013","journal-title":"J. Exp. Med."},{"issue":"7470","key":"10.1016\/j.clim.2016.11.010_bb0440","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12526","article-title":"Type 2 innate lymphoid cells control eosinophil homeostasis","volume":"502","author":"Nussbaum","year":"2013","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.clim.2016.11.010_bb0445","first-page":"1357","article-title":"Phenotypic analysis of infiltrating cells in human myocarditis. An immunohistochemical study in paraffin-embedded tissue","volume":"113","author":"Chow","year":"1989","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0450","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/jaut.2000.0492","article-title":"From infection to autoimmunity","volume":"16","author":"Fairweather","year":"2001","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0455","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.4049\/jimmunol.137.5.1695","article-title":"Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis","volume":"137","author":"Godeny","year":"1986","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2016.11.010_bb0460","doi-asserted-by":"crossref","first-page":"e40797","DOI":"10.1371\/journal.pone.0040797","article-title":"The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1\/2","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2016.11.010_bb0465","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-1775","article-title":"Calcipotriol increases hCAP18 mRNA expression but inhibits extracellular LL37 peptide production in IL-17\/IL-22-stimulated normal human epidermal keratinocytes","author":"Sakabe","year":"2014","journal-title":"Acta Derm. Venereol."},{"issue":"174","key":"10.1016\/j.clim.2016.11.010_bb0470","doi-asserted-by":"crossref","first-page":"174ra26","DOI":"10.1126\/scitranslmed.3004812","article-title":"Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma","volume":"5","author":"Barnig","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.clim.2016.11.010_bb0475","doi-asserted-by":"crossref","first-page":"e94492","DOI":"10.1371\/journal.pone.0094492","article-title":"Natural killer cells induce eosinophil activation and apoptosis","volume":"9","author":"Awad","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.clim.2016.11.010_bb0480","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.it.2005.08.008","article-title":"NK cells: elusive players in autoimmunity","volume":"26","author":"Johansson","year":"2005","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0485","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.autrev.2008.03.002","article-title":"NK cells in autoimmunity: a two-edg'd weapon of the immune system","volume":"7","author":"Perricone","year":"2008","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0490","first-page":"17","article-title":"Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC\/NK cell cross talk","volume":"13","author":"Fernandez","year":"2002","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.clim.2016.11.010_bb0495","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis","volume":"1","author":"Guidotti","year":"2006","journal-title":"Annu. Rev. Pathol."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0500","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2010.07.005","article-title":"A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice","volume":"139","author":"Tillmann","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.clim.2016.11.010_bb0505","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clim.2016.11.010_bb0510","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.micinf.2012.05.001","article-title":"Evasion from NK cell-mediated immune responses by HIV-1","volume":"14","author":"Jost","year":"2012","journal-title":"Microbes Infect."},{"issue":"9","key":"10.1016\/j.clim.2016.11.010_bb0515","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A","article-title":"Recognition of viral hemagglutinins by NKp44 but not by NKp30","volume":"31","author":"Arnon","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"6823","key":"10.1016\/j.clim.2016.11.010_bb0520","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/35059110","article-title":"Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells","volume":"409","author":"Mandelboim","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0525","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0749-0704(03)00006-X","article-title":"A formidable challenge: the diagnosis and treatment of viral myocarditis in children","volume":"19","author":"Wheeler","year":"2003","journal-title":"Crit. Care Clin."},{"issue":"11","key":"10.1016\/j.clim.2016.11.010_bb0530","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0025-6196(11)60670-8","article-title":"Diagnosis and treatment of viral myocarditis","volume":"84","author":"Schultz","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.clim.2016.11.010_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/nrcardio.2015.108","article-title":"Viral myocarditis-diagnosis, treatment options, and current controversies","author":"Pollack","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0540","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00001573-200103000-00001","article-title":"Diagnosis and treatment of pediatric viral myocarditis","volume":"16","author":"Levi","year":"2001","journal-title":"Curr. Opin. Cardiol."},{"issue":"12","key":"10.1016\/j.clim.2016.11.010_bb0545","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1006\/jmcc.2000.1242","article-title":"Effect of interleukin-18 on viral myocarditis: enhancement of interferon- gamma and natural killer cell activity","volume":"32","author":"Kanda","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.clim.2016.11.010_bb0550","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.4049\/jimmunol.1301282","article-title":"Fatal eosinophilic myocarditis develops in the absence of IFN-gamma and IL-17A","volume":"191","author":"Barin","year":"2013","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2016.11.010_bb0555","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.4049\/jimmunol.156.8.2948","article-title":"A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa","volume":"156","author":"de Haas","year":"1996","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0560","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2249.1996.tb08295.x","article-title":"Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II)","volume":"103","author":"Jawahar","year":"1996","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2016.11.010_bb0565","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V88.8.3022.bloodjournal8883022","article-title":"Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections","volume":"88","author":"de Vries","year":"1996","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.clim.2016.11.010_bb0570","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S1286-4579(02)00038-2","article-title":"Human natural killer cell deficiencies and susceptibility to infection","volume":"4","author":"Orange","year":"2002","journal-title":"Microbes Infect."},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0575","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cyto.2005.07.013","article-title":"Do NK cells regulate human autoimmunity?","volume":"32","author":"Pazmany","year":"2005","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0580","first-page":"223","article-title":"Rheumatoid arthritis serum or synovial fluid and interleukin 2 abnormally expand natural killer-like cells that are potent stimulators of IgM rheumatoid factor","volume":"19","author":"Santiago-Schwarz","year":"1992","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.clim.2016.11.010_bb0585","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/rheumatology\/keg240","article-title":"Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype","volume":"42","author":"Pridgeon","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.clim.2016.11.010_bb0590","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/art.10410","article-title":"A subset of natural killer cells is greatly expanded within inflamed joints","volume":"46","author":"Dalbeth","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.clim.2016.11.010_bb0595","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.4049\/jimmunol.173.10.6418","article-title":"CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation","volume":"173","author":"Dalbeth","year":"2004","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2016.11.010_bb0600","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3324\/haematol.2009.012161","article-title":"Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches","volume":"94","author":"Zambello","year":"2009","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0605","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0037-1963(03)00134-3","article-title":"Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes","volume":"40","author":"Zambello","year":"2003","journal-title":"Semin. Hematol."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0610","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2015.05.019","article-title":"Interleukin-33 and interferon-gamma counter-regulate group 2 innate lymphoid cell activation during immune perturbation","volume":"43","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.clim.2016.11.010_bb0615","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1586\/eci.13.36","article-title":"Lipoxin A4: a new direction in asthma therapy?","volume":"9","author":"Barnig","year":"2013","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"16","key":"10.1016\/j.clim.2016.11.010_bb0620","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/0008-5472.CAN-11-3873","article-title":"Primary tumor hypoxia recruits CD11b+\/Ly6Cmed\/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche","volume":"72","author":"Sceneay","year":"2012","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.clim.2016.11.010_bb0625","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/eji.201343448","article-title":"Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC","volume":"43","author":"Balsamo","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"43","key":"10.1016\/j.clim.2016.11.010_bb0630","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1304790110","article-title":"Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia","volume":"110","author":"Baginska","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.clim.2016.11.010_bb0635","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1073\/pnas.1315943111","article-title":"Ischemic neurons recruit natural killer cells that accelerate brain infarction","volume":"111","author":"Gan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0640","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.4049\/jimmunol.1300358","article-title":"TLR2 signaling in tubular epithelial cells regulates NK cell recruitment in kidney ischemia-reperfusion injury","volume":"191","author":"Kim","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.11.010_bb0645","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","article-title":"Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction","volume":"62","author":"Yan","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"11","key":"10.1016\/j.clim.2016.11.010_bb0650","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/TP.0000000000000101","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand on NK cells protects from hepatic ischemia-reperfusion injury","volume":"97","author":"Fahrner","year":"2014","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0655","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clim.2008.08.008","article-title":"NK and NKT cells in liver injury and fibrosis","volume":"130","author":"Notas","year":"2009","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0660","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1586\/17474124.1.1.173","article-title":"Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis","volume":"1","author":"Gao","year":"2007","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0665","first-page":"e20","volume":"96","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0670","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.2010.211136","article-title":"Amelioration of hepatic fibrosis by NK cell activation","volume":"60","author":"Muhanna","year":"2011","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.clim.2016.11.010_bb0675","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaut.2010.09.003","article-title":"CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation","volume":"35","author":"Hintermann","year":"2010","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0680","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.27137","article-title":"Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice","volume":"60","author":"Yi","year":"2014","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clim.2016.11.010_bb0685","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bbadis.2012.09.008","article-title":"Natural killer and natural killer T cells in liver fibrosis","volume":"1832","author":"Gao","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0690","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"130","author":"Radaeva","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0695","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/cvr\/cvu208","article-title":"Natural killer cell crosstalk with allogeneic human cardiac-derived stem\/progenitor cells controls persistence","volume":"104","author":"Boukouaci","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.clim.2016.11.010_bb0700","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fimmu.2014.00439","article-title":"Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective","volume":"5","author":"Eguizabal","year":"2014","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0705","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/cmi.2013.10","article-title":"NK cell-based immunotherapy for malignant diseases","volume":"10","author":"Cheng","year":"2013","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2016.11.010_bb0710","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nm0315-207","article-title":"Natural killers: cataloging immune cells for immunotherapy","volume":"21","author":"Keener","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2016.11.010_bb0715","article-title":"Bench to bedside: NK cells and control of metastasis","author":"Krasnova","year":"2015","journal-title":"Clin. Immunol."},{"issue":"24","key":"10.1016\/j.clim.2016.11.010_bb0720","doi-asserted-by":"crossref","first-page":"13140","DOI":"10.1073\/pnas.94.24.13140","article-title":"Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy","volume":"94","author":"Porgador","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2016.11.010_bb0725","article-title":"Natural killer cell adoptive immunotherapy: coming of age","author":"Baggio","year":"2016","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2016.11.010_bb0730","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00002371-200001000-00018","article-title":"Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer","volume":"23","author":"de Magalhaes-Silverman","year":"2000","journal-title":"J. Immunother."},{"issue":"3b","key":"10.1016\/j.clim.2016.11.010_bb0735","first-page":"1861","article-title":"Autologous natural killer cell therapy for human recurrent malignant glioma","volume":"24","author":"Ishikawa","year":"2004","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.clim.2016.11.010_bb0740","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0959-8049(94)90460-X","article-title":"Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2","volume":"30A","author":"Escudier","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.clim.2016.11.010_bb0745","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0065-2776(04)86006-1","article-title":"Interleukin-2, interleukin-15, and their roles in human natural killer cells","volume":"86","author":"Becknell","year":"2005","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.clim.2016.11.010_bb0750","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.0105-2896.2004.00199.x","article-title":"Cytokines in cancer immunity and immunotherapy","volume":"202","author":"Smyth","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2016.11.010_bb0755","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1054-3589(04)51013-X","article-title":"Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma","volume":"51","author":"Farag","year":"2004","journal-title":"Adv. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2016.11.010_bb0760","first-page":"S2","article-title":"Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer","volume":"6","author":"Rosenberg","year":"2000","journal-title":"Cancer J. Sci. Am."},{"issue":"5","key":"10.1016\/j.clim.2016.11.010_bb0765","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/09546634.2013.813897","article-title":"Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2","volume":"25","author":"Ma","year":"2014","journal-title":"J. Dermatolog. Treat."},{"issue":"23","key":"10.1016\/j.clim.2016.11.010_bb0770","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","article-title":"Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer","volume":"313","author":"Rosenberg","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0775","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bmt.1704086","article-title":"IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I\/II trial","volume":"32","author":"Burns","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.clim.2016.11.010_bb0780","doi-asserted-by":"crossref","first-page":"e20740","DOI":"10.1371\/journal.pone.0020740","article-title":"Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process","volume":"6","author":"Spanholtz","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.clim.2016.11.010_bb0785","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jcyt.2013.06.017","article-title":"Treatment of patients with advanced cancer with the natural killer cell line NK-92","volume":"15","author":"Tonn","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.clim.2016.11.010_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2016.05.018","article-title":"Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells","author":"Burga","year":"2016","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.clim.2016.11.010_bb0795","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/cgt.2011.66","article-title":"Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor","volume":"19","author":"Tassev","year":"2012","journal-title":"Cancer Gene Ther."},{"issue":"15","key":"10.1016\/j.clim.2016.11.010_bb0800","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1158\/1078-0432.CCR-08-2810","article-title":"2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells","volume":"15","author":"Altvater","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.clim.2016.11.010_bb0805","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-12-3558","article-title":"A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells","volume":"73","author":"Chang","year":"2013","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.clim.2016.11.010_bb0810","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1600-6143.2010.03086.x","article-title":"Natural killer cells and the immune response in solid organ transplantation","volume":"10","author":"van der Touw","year":"2010","journal-title":"Am. J. Transplant."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616301656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616301656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T02:00:05Z","timestamp":1692583205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616301656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":162,"alternative-id":["S1521661616301656"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2016.11.010","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cells in inflammatory heart disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2016.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}